Risk Factors Associated with Disease Recurrence among Patients with Low-Risk Papillary Thyroid Cancer Treated at the University of the Philippines-Philippine General Hospital
Maria Cristina Magracia Jauculan (Jauculan MCM), Myrna Buenaluz-Sedurante (Buenaluz-Sedurante M), Cecilia Alegado Jimeno (Jimeno CA)
Endocrinol Metab. 2016;31(1):113-119.   Published online 2016 Mar 16     DOI: https://doi.org/10.3803/EnM.2016.31.1.113
Citations to this article as recorded by Crossref logo
Recurrent Papillary Thyroid Carcinoma to the Cervical Lymph Nodes: Outcomes of Compartment-Oriented Lymph Node Resection
Carlos Gustavo Rivera-Robledo, David Velázquez-Fernández, Juan Pablo Pantoja, Mauricio Sierra, Bernardo Pérez-Enriquez, Raul Rivera-Moscoso, Mónica Chapa, Miguel F. Herrera
World Journal of Surgery.2019; 43(11): 2842.     CrossRef
Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score–Matched Cohort Study
Suyeon Park, Won Gu Kim, Minkyu Han, Min Ji Jeon, Hyemi Kwon, Mijin Kim, Tae-Yon Sung, Tae Yong Kim, Won Bae Kim, Suck Joon Hong, Young Kee Shong
Thyroid.2017; 27(9): 1164.     CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef